WASHINGTON, July 29, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the second quarter of 2013 on Wednesday, July 31, 2013, before the market opens.
The Company will host a conference call at 10:00 AM ET on Wednesday, July 31, 2013, during which Vanda management will discuss the financial results. To participate in the conference call, please dial 1-888-895-5479 (domestic) or 1-847-619-6250 (international) and use passcode 35347357.
The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, July 31, 2013, beginning at 12:00 PM ET and will be accessible until Wednesday, August 7, 2013, at 5:00 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 35347357.ABOUT VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com. Company Contact: Jim KellySenior Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) 734-3428 firstname.lastname@example.org SOURCE Vanda Pharmaceuticals Inc.